The Swiss biosimilars business currently has recurring and scheduled financial investments in Slovenia worth greater than USD 1.1 bn by 2029.
发布者:BY CHRISTOPHER DUE KARLSSON,转转请注明出处:https://robotalks.cn/sandoz-expands-in-slovenia-with-new-production-facility/